Ilan Sobel

Ilan Sobel, CEO of BioHarvest Sciences, leads the charge in revolutionary plant-derived supplements. He discusses how their Botanical Synthesis technology creates potent compounds from grape cells without the waste of traditional methods. The conversation touches on VINIA's impressive clinical results, including a 70% increase in arterial dilation and cognitive benefits. They also delve into alternative compounds like verbascoside from olives and future innovations with saffron, making biohacking more accessible and sustainable.

Ilan Sobel, CEO of BioHarvest Sciences, is on a mission to transform health through plant-based solutions. He discusses the intricate ties between U.S. and Israeli politics and the looming threat from Iran. Sobel emphasizes innovations in plant cell technology as a way to address health and sustainability. The conversation delves into the importance of democratic principles and innovation for peace in the Middle East, while highlighting the role of biotech in enhancing human wellness amidst global challenges.

Ilan Sobel, CEO of BioHarvest Sciences, is revolutionizing botanical synthesis technology. He shares the compelling story behind BioHarvest's mission to democratize plant compounds like Vinia, a powerful resveratrol product derived from red grapes. The conversation dives into the importance of blood flow for energy and cognition and tackles the challenges of sustainable production in biotech. Ilan also reveals how his company’s practices are designed to preserve plant biodiversity while delivering health benefits to the masses.